Acetylcholine synthesis and muscarinic receptor subtype mRNA expression in T-lymphocytes

被引:70
作者
Kawashima, K [1 ]
Fujii, T
Watanabe, Y
Misawa, H
机构
[1] Kyoritsu Coll Pharm, Dept Pharmacol, Minato Ku, Tokyo, Japan
[2] Tokyo Metropolitan Inst Neurosci, Dept Neurol, Fuchu, Tokyo 183, Japan
关键词
acetylcholine; choline acetyltransferase; T-lymphocytes; muscarinic receptor; radioimmunoassay;
D O I
10.1016/S0024-3205(98)00131-3
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We used a sensitive and specific radioimmunoassay for acetylcholine (ACh), and detected significant amounts of ACh in the blood of various mammals, including humans. About 60% of human blood ACh was localized in mononuclear leukocytes. Human leukemic T-cell lines, used as T-lymphocyte models, contained both ACh and choline acetyltransferase (ChAT) activity. Furthermore, ChAT mRNA and protein were detected in the T-cell line MOLT3. Phytohemagglutinin, a T-cell activator, increased both synthesis and release of ACh by MOLTS cells. Muscarinic receptor subtype mRNA expression was confirmed in various T-cell lines. These findings indicate that ACh synthesized by ChAT in T-lymphocytes acts on the muscarinic receptors on lymphocytes in autocrine and/or paracrine pathways and suggest that ACh in blood functions as a modulator of T-cell-dependent immune responses.
引用
收藏
页码:1701 / 1705
页数:5
相关论文
共 28 条
[21]  
MASLINSKI W, 1989, Brain Behavior and Immunity, V3, P1
[22]   INTACT HUMAN-LYMPHOCYTE MEMBRANES RESPOND TO MUSCARINIC RECEPTOR STIMULATION BY OXOTREMORINE WITH MARKED CHANGES IN MICROVISCOSITY AND AN INCREASE IN CYCLIC-GMP [J].
MASTURZO, P ;
SALMONA, M ;
NORDSTROM, O ;
CONSOLO, S ;
LADINSKY, H .
FEBS LETTERS, 1985, 192 (02) :194-198
[23]   THE PARASYMPATHETIC NERVOUS-SYSTEM TAKES PART IN THE IMMUNO-NEUROENDOCRINE DIALOG [J].
RINNER, I ;
SCHAUENSTEIN, K .
JOURNAL OF NEUROIMMUNOLOGY, 1991, 34 (2-3) :165-172
[24]   DETECTION OF CHOLINE-ACETYLTRANSFERASE ACTIVITY IN LYMPHOCYTES [J].
RINNER, I ;
SCHAUENSTEIN, K .
JOURNAL OF NEUROSCIENCE RESEARCH, 1993, 35 (02) :188-191
[25]  
STROM TB, 1981, J IMMUNOL, V127, P705
[26]  
TUCEK S, 1982, J PHYSIOL-LONDON, V322, P53
[27]  
Tucek S., 1988, HDB EXPT PHARM, P125, DOI 10.1007/978-3-642-73220-1_7
[28]   Oral administration of KW-5092, a novel gastroprokinetic agent with acetylcholinesterase inhibitory and acetylcholine release enhancing activities, causes a dose-dependent increase in the blood acetylcholine content of beagle dogs [J].
Yamada, S ;
Fujii, T ;
Kawashima, K .
NEUROSCIENCE LETTERS, 1997, 225 (01) :25-28